- Disease: Acute COVID-19
- Study type: Observational Cohort Study, Treatment
- Study type descriptors: Retrospective, Multicentre
- Objective: To assess the safety, virological, and clinical outcomes of convalescent plasma transfusion in immunocompromised patients hospitalised for COVID-19
- Number of participants enrolled: 81
- Study enrolling from to
- Study includes follow-up for 4 weeks
Study Data
- Adults (18-64 years)
- Elderly (≥65 years)
- Fragile population
- Immunocompromised host
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Acute COVID-19
- Non pharmacological intervention
- Convalescent plasma
External Links
Other information
The information was provided with the aid of the study investigators
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to